产品分类导航
Human Coagulation Factor VIII
Human Coagulation Factor VIII
Human Coagulation Factor VIII

Human Coagulation Factor VIII

更新时间:2025-06-24

立即询盘
收藏

产品详情

产品名称: Human Coagulation Factor VIII
产品分类: 其他生物制剂
药典: 中国药典
级别: 药用级
产品关键词: Human Coagulation Factor VIII
是否为生产商:
主要销售市场: 中/南美洲

产品描述:

Specification:200IU

Description:
Human Coagulation Factor VIII is a white loose powder. After reconstitution, the solution is clear or with slight opalescence.

Shelf-life:36months

Storage:
2-8℃ for storage and transportation, protect from light.

Indications:
Human Coagulation Factor VIII is indicated for correcting the disorder of coagulation due to deficiency of human coagulation Factor VIII, mainly for prevention and control of bleeding in patients with hemophilia A or acquired Factor VIII deficiency, and for treatment of bleeding caused by operation of these patients.

公司简介

法默凯是一家专业从事医药产品国际化和法规技术咨询销售型综合服务商,通过搭建“医药产品进出口贸易、制药技术转移、注册药政咨询、供应链和销售渠道资源整合”四大服务平台,布局蓝海市场,以独特的商业模式,嫁接中国医药产品与全球医药市场!公司业务覆盖全球五大洲、六十多个国家,已获得近300个药品制剂和原料药国内外注册证书,与超过100家国内外专业的医药生产和销售企业建立了紧密的业务合作关系,其中不乏国内外知名的制药企业,并拥诸多制剂和原料的国内外独家销售权。随着公司业务的发展,陆续在巴西、英国、奥地利等地设立了办事处。法默凯拥有一支国际化、专业化、年轻化的高知团队,其中有资深的医药外贸业务精英、精通国内外药品注册法规的专家以及拥有国际风险控制和资本运作的顾问团队。目前在职员工本科及以上学历占比为81%,其中硕士占比38%;医药专业占比53%,外语类专业占比10%;英语以及小语种如西班牙语、葡萄牙语、俄语、法语、日语、韩语作为工作语言的占比超过三分之二,员工平均年龄为33岁。公司近年来业务得到了快速持续增长,并将进一步加大在医药制剂、医药原料等产品注册、认证方面的投入,积极建立自身的品牌,壮大在海外的销售团队,在夯实医药制剂、原料出口非洲传统市场同时,着力开拓南美、东南亚、独联体和中东、大洋洲等国际中高端市场。
注册资本:
企业规模(人):
业务类型:
成立日期:
年销售额:
主营产品类别:

该公司其他产品

Pantoprazole Sodium for Injection
Pantoprazole Sodium for Injection
Specification:200IUDescription:Human Coagulation Factor VIII is a white loose powder. After reconstitution, the solution is clear or with slight opalescence.Shelf-life:36monthsStorage:2-8℃ for storage and transportation, protect from light.Indications:Human Coagulation Factor VIII is indicated for correcting the disorder of coagulation due to deficiency of human coagulation Factor VIII, mainly for prevention and control of bleeding in patients with hemophilia A or acquired Factor VIII deficiency, and for treatment of bleeding caused by operation of these patients.
Human Fibrinogen
Human Fibrinogen
Specification:200IUDescription:Human Coagulation Factor VIII is a white loose powder. After reconstitution, the solution is clear or with slight opalescence.Shelf-life:36monthsStorage:2-8℃ for storage and transportation, protect from light.Indications:Human Coagulation Factor VIII is indicated for correcting the disorder of coagulation due to deficiency of human coagulation Factor VIII, mainly for prevention and control of bleeding in patients with hemophilia A or acquired Factor VIII deficiency, and for treatment of bleeding caused by operation of these patients.
Human Immunoglobulin(pH4) for Intravenous Injection
Human Immunoglobulin(pH4) for Intravenous Injection
Specification:200IUDescription:Human Coagulation Factor VIII is a white loose powder. After reconstitution, the solution is clear or with slight opalescence.Shelf-life:36monthsStorage:2-8℃ for storage and transportation, protect from light.Indications:Human Coagulation Factor VIII is indicated for correcting the disorder of coagulation due to deficiency of human coagulation Factor VIII, mainly for prevention and control of bleeding in patients with hemophilia A or acquired Factor VIII deficiency, and for treatment of bleeding caused by operation of these patients.
南京法默凯医药科技有限公司
注册资本不愿意公开
公司地址
江苏省南京市南京市江宁区金源路2号绿地城际空间站南广场D1栋1401
联系人
查看联系方式
快速询盘
询盘主题
请输入询盘主题
询盘信息
请输入询盘信息
快速发送询盘
2006-2026 上海博华国际展览有限公司版权所有(保留一切权利) 沪ICP备05034851号-57